Company Description
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator.
NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.
| Country | United States |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 16 |
| CEO | David Rosa |
Contact Details
Address: 7599 Anagram Drive Eden Prairie, Minnesota 55344 United States | |
| Phone | 952 426 1383 |
| Website | n1mtc.com |
Stock Details
| Ticker Symbol | NMTC |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001500198 |
| CUSIP Number | 64130M209 |
| ISIN Number | US64130M2098 |
| Employer ID | 27-0863354 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David A. Rosa M.D. | President, Chief Executive Officer and Director |
| Ronald W. McClurg | Chief Financial Officer |
| Steven Mertens | Chief Technology Officer |
| Mark Christianson | Co-Founder, Business Development Director and Medical Sales Liaison |
| Christopher R. Volker CFA | Chief Operating Officer |
| Hijaz Haris | Vice President of Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 17, 2024 | 8-K | Current Report |
| Dec 17, 2024 | 10-K | Annual Report |
| Nov 25, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | SCHEDULE 13G/A | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | 8-K | Current Report |
| Oct 31, 2024 | 8-K | Current Report |
| Sep 13, 2024 | EFFECT | Notice of Effectiveness |
| Sep 13, 2024 | 8-K | Current Report |
| Sep 12, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |